Earnings
IMUX
14.31
-4.41%
-0.66
Currencies: USD
Items
Total Revenue
Revenue
Cost of Revenue
Gross Profit
Marketing and Administrative Expenses
Research and Development Costs
Financial Expenses
Depreciation and Amortization
Other Expenses
Total Operating Expenses
Asset Impairments
Operating Income
Interest Income
Assets Disposal
Other Non-operating Net Income
Non-operating Income
Net Income Before Taxes
Provision for Income Taxes
Net Income
Minority Interests
Net Income Attributable to Shareholders
Net Income Attributable to Common Equities
Net Income from Discontinued Operations
Basic EPS
Diluted EPS
FY 2020-12-31
0.00
--
--
--
10.33M
38.64M
--
--
--
48.97M
--
-48.97M
58.00K
--
4.90M
--
-44.02M
--
-44.02M
--
-44.02M
-44.02M
--
--
-2.81
FY 2019-12-31
0.00
--
--
--
14.52M
22.51M
--
--
--
37.03M
--
-37.03M
107.00K
--
1.99M
--
-34.93M
--
-34.93M
--
-34.93M
-34.93M
--
--
-4.52
FY 2018-12-31
0.00
0.00
--
--
13.59M
24.82M
--
--
--
42.02M
--
-42.02M
521.00K
--
28.00K
--
-41.48M
--
-41.48M
--
-41.48M
-41.48M
--
--
-39.16
FY 2017-12-31
0.00
0.00
--
--
13.31M
39.34M
--
--
--
52.66M
--
-52.66M
650.00K
--
-73.00K
--
-52.08M
--
-52.08M
--
-52.08M
-52.08M
--
--
-52.26
FY 2016-12-31
0.00
0.00
--
--
11.22M
30.05M
--
--
--
41.27M
--
-41.27M
284.00K
--
13.00K
--
-40.97M
--
-40.97M
--
-40.97M
-40.97M
--
--
-52.21

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out IMUX latest quarterly and annual financial reports. There are also past financial reports for you to reference. You can analyze Immunic Inc recent business situations from balance sheets, income statements, cash flow statements and other tables. This information may help you make smarter investment decisions.